Who Owns Spyre Therapeutics Stock?
NASDAQ: SYREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 106.80%
- Institutions (% of float)
- 108.52%
- Held by insiders
- 1.58%
- Institutional holders
- 382
- Institutions 98.4%
- Insiders 1.6%
- Public and other 0.0%
Who owns Spyre Therapeutics stock?
Institutional investors own about 106.8% of Spyre Therapeutics's shares, spread across 382 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.58% of SYRE.
The largest institutional holders are FMR, LLC (12.78%), Blackrock Inc. (6.38%) and Perceptive Advisors Llc (4.24%). Together, the top 10 institutions control 46.3% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their SYRE positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SYRE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 13.03M | 12.78% | +10.6% |
| Blackrock Inc. | 6.51M | 6.38% | +17.9% |
| Perceptive Advisors Llc | 4.32M | 4.24% | +14.2% |
| RTW Investments LP | 4.25M | 4.17% | +1.9% |
| Paradigm Biocapital Advisors LP | 3.84M | 3.77% | +96.2% |
| Vanguard Capital Management LLC | 3.45M | 3.38% | +12.8% |
| State Street Corporation | 3.06M | 3.00% | +17.3% |
| Venrock Adviser, LLC | 2.99M | 2.93% | -19.0% |
| Price (T.Rowe) Associates Inc | 2.96M | 2.91% | +85.2% |
| Driehaus Capital Management, LLC | 2.80M | 2.75% | +0.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SYRE
| Fund | Shares | % Held |
|---|---|---|
| SmallCap World Fund Inc | 2.78M | 2.73% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.76M | 2.71% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.48M | 2.44% |
| iShares Trust-iShares Russell 2000 ETF | 1.90M | 1.86% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.40M | 1.37% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 896.56K | 0.88% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 886.18K | 0.87% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 857.35K | 0.84% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 814.29K | 0.80% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 804.72K | 0.79% |
Frequently asked questions
Who is the largest shareholder of Spyre Therapeutics?
FMR, LLC is the largest institutional shareholder of SYRE, owning 12.78% of shares outstanding (13.03M shares) as of its latest 13F filing.
What percentage of Spyre Therapeutics is owned by institutions?
Institutions own about 106.8% of SYRE shares and 108.5% of the public float.
How much of Spyre Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.58% of SYRE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.